Liège to London: riding for Guy’s Cancer
A mammoth 300-mile, 3-day cycle from the Belgian city of Liège to the Cancer Centre at Guy's, London
What is the Liège to London bike ride?
The Liège to London Bike Ride is a 300-mile, three-day cycle from the Belgian City of Liège to the Cancer Centre at Guy’s, London, between 19 - 21 September 2019.
It is the brainchild of cancer survivor Gary Saunders, who participated in a previous fundraising cycle challenge from Land’s End to London in 2016.
This time, the road is even longer. The ride is both a celebration of survivorship and an opportunity to raise funds for vital research and treatment. Monies raised will help more people who are diagnosed with urological cancers such as prostate, testicular, kidney and bladder cancer.
Mark and Luke Ashworth
We take some time out with Mark Ashworth and his son Luke, to hear their story and find out how preparations are going for Liège to London.
Watch the riders in action
A team of 18 valiant cyclists took on the Liège to London Bike Ride, covering a mammoth 300 miles in three days, to raise money for the Cancer Centre at Guy’s. Watch them in action and hear what some of them had to say at the end.
Who will be cycling from Liège to London?
An 18-strong team, including cancer survivors, dedicated cancer professionals, friends and family, will ride together on a physically demanding route through rural and urban landscapes across two countries.
Gary will be joined by prostate cancer survivor, now King’s College London researcher Dr Mark Ashworth. They will also be joined by teammates Dr Simon Hughes and Dr Deborah Enting, both of whom are dedicated clinicians, as well as committed fundraisers for Guy’s Cancer.
Why are the riders taking part in Liège to London?
Each rider has a different story to tell, for some, it’s personal, for others it's professional and in some cases, both. Although each individual’s motivation is different, they share a common goal: to raise funds to develop vital research for the urology centre at Guy’s Cancer.
What will the money fund?
The money raised from Liège to London will fund further scientific research and clinical treatment in relation to urological cancers including developing immunotherapy. This is a type of treatment that involves taking medicines that encourage the immune system to fight cancer, infections, and other diseases.
In urology, it is effective for kidney, bladder and prostate cancers. But not all patients respond to this type of treatment, so Guy’s Cancer researchers will look at finding ways of predicting who will respond to immunotherapy, find new related treatment options for patients who do not currently respond, and enhance immunotherapy responses while reducing side effects.
Another research project will investigate whether directing chemotherapy to the bladder can reduce the number of patients developing bladder cancer after receiving treatment for a similar cancer in the kidney.
Sign up to hear more about Guy's Cancer
One of the UK’s leading providers of care and treatment for people with cancer